Abstract:Background: Mismatch repair deficiency (dMMR) due to germline mutations in DNA repair genes including MLH1, MSH2, MSH6 and PMS2, or somatic aberrant silencing of MLH1, is a well-established feature for Lynch syndrome, a major type of hereditary colorectal cancer (CRC). The purpose of this study is to derive prevalence of germline MMR gene mutations in Chinese population with dMMR CRC. Methods: ColonCore panel is designed for simultaneous detection of microsatellite instabiligy (MSI) status of 22 regions and mutations in 38 CRC-related genes. Whole exons of the 38 genes were covered by the panel. The MSI phenotype detection method was a read-count-distribution-based approach. It utilized the coverage ratio of a specific set of repeat lengths as the main characteristic of each microsatellite locus, and categorized a locus as unstable if the coverage ratio was less than a given threshold. The MSI status of a sample was determined by the percentage of unstable loci in the given sample. Results: Among 1394 postsurgical CRC patients whose MMR status were detected by immunohistochemistry (IHC), 99 patients were dMMR, accounting for 7.1%. The concordance rate was 92.3% between MSI and IHC. Next, we investigated the germline mutation spectrum of dMMR patients. About 26.3% patients harbored pathogenic germline MMR gene mutations, with 13%, 6%, 5% and 2% of patients carrying pathogenic MLH1, MSH2, MSH6 and PMS2 mutations, respectively. Specially, about 30% pathogenic MLH1 mutation occured in splice region. Among patients with pathogenic MMR gene mutations, their first cancer was diagnosed ranging from 22 to 69 years old with median age at diagnosis was 50, and only 57% have a family history of ≥ 1 relative with Lynch syndrome related cancers. Furthermore, 3% harbored pathogenic mutations in other genes. Approximately, 17% of patients harbored MMR gene variants of unknown significance (VUS) and 26% harbored other VUS. The remaining 28% of patients had no pathogenic or VUS mutations from this panel. Conclusions: The prevalence rate of germline pathogenic mutations is 26% in dMMR CRC patients, accounting for 1.8% of all resectable CRC patients. Median age at diagnosis of Lynch syndrome related cancers is 50 years old and nearly 40% Lynch syndrome patients have no family history. Legal entity responsible for the study: Ying Yuan. Funding: Burning Rock Biotech. Disclosure: C. Liu: Burning Rock Biotech. All other authors have declared no conflicts of interest.

Polymorphisms in Mismatch Repair Genes Are Associated with Risk and Microsatellite Instability of Gastric Cancer, and Interact with Life Exposures

The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: A meta-analysis

A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer

Mismatch Repair Gene Mlh3 Pro844leu And Thr942ile Polymorphisms And The Susceptibility To Cervical Carcinoma And Hpv Infection: A Case-Control Study In A Chinese Population

A Genetic Variant In Mir-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis Of 15 Case-Control Studies

Correlation between hMLH1-93G/A gene polymorphism and colorectal cancer

A Polymorphism Within The Mismatch Repair Gene Predicts Prognosis And Adjuvant Chemotherapy Benefit In Gastric Cancer Patients.

Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis

Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma.

Single Nucleotide Polymorphisms of DNA Mismatch Repair Genes MSH2 and MLH1 Confer Susceptibility to Esophageal Cancer.

MLH 1 Polymorphisms and Cancer Risk : a Meta-analysis Based on 33 Case-control Studies

Variations in Exon 7 of the MSH2 Gene and Susceptibility to Gastrointestinal Cancer in a Chinese Population

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

Association of Polymorphisms of Mismatch Repair Genes hMLHI and hMSH2 with Breast Cancer Susceptibility: A Meta-Analysis

Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.

Polymorphisms In Hmlh1 And Risk Of Early-Onset Lung Cancer In A Southeast Chinese Population

DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis

Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks.

Polymorphisms in the XPG Gene and Risk of Gastric Cancer in Chinese Populations

Mdm4 Genetic Variants and Risk of Gastric Cancer in an Eastern Chinese Population

MUC1 gene polymorphism rs4072037 and susceptibility to gastric cancer: a meta-analysis.